A citation-based method for searching scientific literature


List of co-cited articles
861 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
23

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
15



Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
Ian H de Boer, Wanjie Sun, Patricia A Cleary, John M Lachin, Mark E Molitch, Michael W Steffes, Bernard Zinman. N Engl J Med 2011
344
12

Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
Zhuo Chen, Feng Miao, Andrew D Paterson, John M Lachin, Lingxiao Zhang, Dustin E Schones, Xiwei Wu, Jinhui Wang, Joshua D Tompkins, Saul Genuth,[...]. Proc Natl Acad Sci U S A 2016
110
11


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
11

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
780
11

Mechanisms of diabetic complications.
Josephine M Forbes, Mark E Cooper. Physiol Rev 2013
10

UKPDS and the legacy effect.
John Chalmers, Mark E Cooper. N Engl J Med 2008
153
9

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
John M Lachin, Saul Genuth, Patricia Cleary, Matthew D Davis, David M Nathan. N Engl J Med 2000
9


Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes.
Feng Miao, Zhuo Chen, Saul Genuth, Andrew Paterson, Lingxiao Zhang, Xiwei Wu, Sierra Min Li, Patricia Cleary, Arthur Riggs, David M Harlan,[...]. Diabetes 2014
133
9

Epigenetic mechanisms in diabetic complications and metabolic memory.
Marpadga A Reddy, Erli Zhang, Rama Natarajan. Diabetologia 2015
239
9



Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
7

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
Per-Henrik Groop, Merlin C Thomas, John L Moran, Johan Wadèn, Lena M Thorn, Ville-Petteri Mäkinen, Milla Rosengård-Bärlund, Markku Saraheimo, Kustaa Hietala, Outi Heikkilä,[...]. Diabetes 2009
372
7


Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
Trevor J Orchard, David M Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C Backlund, John M Lachin. JAMA 2015
257
7

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
7

Oxidative stress and diabetic complications.
Ferdinando Giacco, Michael Brownlee. Circ Res 2010
6

Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail.
Daniella Brasacchio, Jun Okabe, Christos Tikellis, Aneta Balcerczyk, Prince George, Emma K Baker, Anna C Calkin, Michael Brownlee, Mark E Cooper, Assam El-Osta. Diabetes 2009
341
6

Diabetic kidney disease: a report from an ADA Consensus Conference.
Katherine R Tuttle, George L Bakris, Rudolf W Bilous, Jane L Chiang, Ian H de Boer, Jordi Goldstein-Fuchs, Irl B Hirsch, Kamyar Kalantar-Zadeh, Andrew S Narva, Sankar D Navaneethan,[...]. Diabetes Care 2014
426
6

Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory.
S Roy, R Sala, E Cagliero, M Lorenzi. Proc Natl Acad Sci U S A 1990
327
6

Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia.
Assam El-Osta, Daniella Brasacchio, Dachun Yao, Alessandro Pocai, Peter L Jones, Robert G Roeder, Mark E Cooper, Michael Brownlee. J Exp Med 2008
683
6

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
6


Molecular mechanisms of diabetic kidney disease.
Kimberly Reidy, Hyun Mi Kang, Thomas Hostetter, Katalin Susztak. J Clin Invest 2014
368
6

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
T Nishikawa, D Edelstein, X L Du, S Yamagishi, T Matsumura, Y Kaneda, M A Yorek, D Beebe, P J Oates, H P Hammes,[...]. Nature 2000
6

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
6

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
6

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
David M Nathan, John Lachin, Patricia Cleary, Trevor Orchard, David J Brillon, Jye-Yu Backlund, Daniel H O'Leary, Saul Genuth. N Engl J Med 2003
596
6

Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
6

An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy.
Mitsuo Kato, Mei Wang, Zhuo Chen, Kirti Bhatt, Hyung Jung Oh, Linda Lanting, Supriya Deshpande, Ye Jia, Jennifer Y C Lai, Christopher L O'Connor,[...]. Nat Commun 2016
129
6

Long-term follow-up after tight control of blood pressure in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, H Andrew W Neil, David R Matthews. N Engl J Med 2008
468
6

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
6

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN.
Mitsuo Kato, Sumanth Putta, Mei Wang, Hang Yuan, Linda Lanting, Indu Nair, Amanda Gunn, Yoshimi Nakagawa, Hitoshi Shimano, Ivan Todorov,[...]. Nat Cell Biol 2009
453
5

Epigenetic histone methylation modulates fibrotic gene expression.
Guangdong Sun, Marpadga A Reddy, Hang Yuan, Linda Lanting, Mitsuo Kato, Rama Natarajan. J Am Soc Nephrol 2010
162
5

Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells.
Hang Yuan, Marpadga A Reddy, Guangdong Sun, Linda Lanting, Mei Wang, Mitsuo Kato, Rama Natarajan. Am J Physiol Renal Physiol 2013
94
5

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Mitsuo Kato, Jane Zhang, Mei Wang, Linda Lanting, Hang Yuan, John J Rossi, Rama Natarajan. Proc Natl Acad Sci U S A 2007
530
5

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
5

Oxidative stress as a major culprit in kidney disease in diabetes.
Josephine M Forbes, Melinda T Coughlan, Mark E Cooper. Diabetes 2008
739
5




Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
5

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.